Business
Endexx Collaborates with C3 Global Biosciences to Serve in the Advancement of Cannabis Science
Endexx Collaborates with C3 Global Biosciences to Serve in the Advancement of Cannabis Science.
About this update from Endexx Corp.
[{"type":"text","content":"\n \n \n Endexx Collaborates with C3 Global Biosciences to Serve in the Advancement of Cannabis Science\n \n \nEndexx Collaborates with C3 Global Biosciences to Serve in the Advancement of Cannabis Science\n\nC3 signs MOU with Endexx to be acquired\n\n \n CAVE CREEK, AZ--(Marketwired - Sep 26, 2017) - Endexx Corporation (OTC PINK: EDXC), a provider of innovative phyto-nutrient-based food and nutritional products, is pleased to report it has entered into a Memorandum of Understanding (MOU) with C3 Global Biosciences, Inc., a cause-driven organization committed to developing sustainable health solutions through the advancement of cannabis science. The collaboration will be aimed at expanding market knowledge and expertise in establishing both companies as key players in the cannabidiol (CBD) market. The company is led by CEO Andrew Serafini and Chief Medical Officer Dr. HJ Raza MD/PhD along with Rene´ Crysler, Vice President, who is a pioneer in the cannabis industry.\n CEO Todd Davis commented, \"Endexx has been seeking the right team of people to bring into the company. The C3GBS team brings the necessary expertise and support structure into Endexx to continue our leadership in the CBD industry and set the standards for this emerging market.\" Mr. Davis further stated, \"Rarely does a team of strong-willed, supremely qualified individuals with passion and purpose, come together in one company. Through our collaborative efforts, the joined forces will soon emerge as one of the top growth companies in the U.S.\"\n C3GBS, a rapidly emerging biopharmaceutical company and producer of premium CBD products, has been actively securing strategic partnerships and alliances with key companies. CEO Andrew Serafini explains, \"Todd Davis and the skilled team at Endexx bring the necessary talent and mindset that is required to have a significant global impact, and really drive change. Our mission, focused strategy and strong culture is in clear alignment with the Endexx mission, and we are poised for rapid growth and expansion with the right team.\" \n C3GBS is currently expanding its executive management team and has recruited Jeanine \"Nini\" Martin, as Chief Growth Officer and Lisanne Haigh, Director of Sales. Jeanine \"Nini\" Martin, FHIMSS, FACHE, has been in the Global Healthcare Industry for the past 25 years and is a welcomed add...